CervoMed reports 32-week data showing neflamapimod slowed DLB progression and reduced neurodegeneration biomarkers with good ...

Enterprise beats earnings expectations but misses on revenue in Q2 2025. Set multiple operating records despite market ...

AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer ...

Shares of NIO are trading flat Monday. The stock is holding steady after a marked 43% rally over the past month.

Analysts expect Boston Props to report an earnings per share (EPS) of $0.88. The announcement from Boston Props is eagerly ...

Analysts expect Hubbell to report an earnings per share (EPS) of $4.38. Investors in Hubbell are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive ...

In terms of consensus rating, Incyte is in the middle compared to its peers. Incyte has the highest revenue growth among its peers. Incyte also has the highest gross profit. However, Incyte has the ...

Shares of CEA Industries Inc (NASDAQ:VAPE) are soaring in Monday morning trading following the announcement of a strategic ...

Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a ...

After working at Instagram for a little over three years, Choo has pivoted once again. She recently launched Interview Master ...

Barclays analyst Kannan Venkateshwar maintained Charter Communications with an Underweight rating and lowered the price ...

The P2P Foundation and the Commons Foundation have jointly introduced SatoshiMeme (CRYPTO: SATOSHI), a project that aims to ...